Kalbe continues to maintain its position as the leading player in Indonesia’s prescription pharmaceuticals market. Through its Prescription Pharmaceuticals Division, the Company carries a comprehensive range of products for all income groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs for the country’s rising middle and premium segments.
This Division’s marketing team comprising medical representatives is considered as the largest marketing arm in the country, which has become one of Prescription Pharmaceuticals Division’s competitive edges for many years. Moreover, this Division is also supported by one of the widest distribution network in the country, serving hospitals, pharmacies and drug stores across Indonesia’s entire archipelago.
Some of Kalbe’s top products include Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG.
For further information, please access www.kalbemed.com